Regulatory Strategy Focus Dunn Regulatory Associates specializes in regulatory strategy, FDA and EU negotiations, IND maintenance, and CTD/IB/meeting package preparation, indicating strong potential upsell opportunities for comprehensive regulatory consulting and document management across Rx, OTC, biopharma, devices, and cosmetics.

US Agent Services Core offering includes US Agent services, providing a pathway to expand client access to US regulatory processes, a service that could be cross-sold to global clients seeking streamlined US market entry and ongoing regulatory liaison.

Regulatory Pathways Expertise Experience with expedited pathways such as Breakthrough therapy suggests opportunities to approach high-potential, fast-track programs, including early engagement, strategy development, and alignment with accelerated development timelines.

Growth Readiness Mid-sized firm with revenue in the multi‑million range and a lean employee base signals flexibility for tiered service packages, retainer models, or project-based engagements tailored to evolving regulatory needs of growing biotech, pharma, and device clients.

Market Positioning Competitive landscape includes large CROs and consultancies; Dunn can differentiate by targeted regulatory strategy, integrated development planning, and pragmatic issue resolution, presenting a value proposition for small to mid-market companies seeking specialized regulatory depth.